April 16, 2013–The Plasma Protein Therapeutics Association (PPTA) recognizes World Hemophilia Day, an annual international event sponsored by the World Federation for Hemophilia (WFH) that seeks to raise awareness of people living with inherited bleeding disorders.
Last week, the President and Congress could not come to an agreement and on March 1, 2013 sequestration, $85 billion in across the board federal spending cuts, went into effect.
The Plasma Protein Therapeutics Association (PPTA) joins over 300 organizations in 56 countries in recognizing the 6th annual International Rare Disease Day on February 28.
The Plasma Protein Therapeutics Association (PPTA) is proud to announce that the Global Board of Directors elected Paolo Marcucci, as Chairman at its meeting in Brussels, Belgium today.
The Plasma Protein Therapeutics Association (PPTA) applauds the House of Representatives on yesterday's passage of the Medicare IVIG Access Act (H.R. 1845), which gives Medicare patients who suffer from primary immunodeficiency disease (PI) better access to lifesaving intravenous immune globulin (IVIG) therapy at home.
The Plasma Protein Therapeutics Association (PPTA) has awarded UNICAplasma, s. r. o. with International Quality Plasma Program (IQPP) certification for its plasma collection center in Prague.
PPTA presents at the European Haemophilia Consortium Roundtable Event on Health Technology Assessment.
PPTA presents at the 15th Biennial Meeting of the European Society of Immunodeficiencies (ESID 2012) held in collaboration with the International Patient Organisation of Patients with Immunodeficiency (IPOPI) and the International Nurses Group for Immune Deficiency (INGID).
Over 300 patients, policymakers and industry representatives convened in Washington, DC on June 21-22 for the 2012 Plasma Protein Forum. The conference centered on the theme of rare diseases.
A documentary premiered at the June 20th Gala event in Washington, D.C. celebrating PPTA's 20th Anniversary. The documentary recognizes the significant contributions of PPTA members to patients around the world.
